Also, progression of pancreatic cancer is linked with up-regulation of EGFR [154] and the glycoprotein over-expression has been noticed in human pancreatic cancer, a cell line that is up to 85% of ductal adenocarcinomas whereas percentage of silent mutation was 81% [154, 155]. This evidence concerns the gene EGFR and familial pancreatic carcinoma.